Rob’s Fundamental Stock Analysis

Rob’s Fundamental Stock Analysis

Share this post

Rob’s Fundamental Stock Analysis
Rob’s Fundamental Stock Analysis
$axsm follow up

$axsm follow up

Rob's Educated Guesses's avatar
Rob's Educated Guesses
Oct 23, 2022
∙ Paid
2

Share this post

Rob’s Fundamental Stock Analysis
Rob’s Fundamental Stock Analysis
$axsm follow up
Share

I received good follow up questions about $AXSM and its pricing strategy as a new novel drug in MDD vs traditional now generic serotonin drugs like Zoloft.  No doubt, the entire 20 million plus patient population is not moving to Auvelity tomorrow.  In fact, it never will.  The trajectory of the prescription ramp always takes time and education from KOL…

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Fein Luxe LLC
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share